OTC Proprietary MDI Compounds and Products On The Market
MDI 403 Retextra® is the driving ingredient in the MDI anti-acne product SensiClear.
MDI 403 Retextra® is the driving ingredient in Uth Radiance Serum
Proprietary MDI Compound in Development
MDI 301, proprietary drug compound, works effectively and safely for skin repair and wound healing. Documentation, data, and patent positions are available on request.
Let's Talk About Your Project
Molecular Design International, Inc.
changing the world,
one molecule at a time
© 2016 Molecular Design International, Inc.
Connect and Follow
1138 North Germantown Parkway
Cordova, TN 38016
Phone (901) 747-3366
Fax (901) 747-5606